Transparency Market Research’s report on the Ribonucleic Acid Interference (RNAi) technologies market offers an analytical snapshot of this highly dynamic market within the pharmaceutical industry. This report provides an overview of the global RNAi technologies scenario, before detailing each critical segment-based on type, application, and products-within this market. As well as estimating market value of the RNAi technologies market in USD million, the report provides accurate market forecasts for market size and production. In this market intelligence report, our analysts discuss in detail figures across each vertical within this market. The report further analyzes the projected RNAi technologies industry growth rate, capacity, and structure. We also provide an analytical overview of the historical data. Other important aspects, such as growth drivers and restraining factors are enumerated in this market research report.
This report is a discussion of the overall landscape of the RNAi technologies market, focusing on the competitive and regulatory environment, the value chain, and the bargaining power of key stakeholders.
RNAi is a mechanism of gene regulation, and an important pathway that is used by many different organisms. Entities in the biotechnology and pharmaceutical world are taking an active interest in RNAi technology, as it is poised to substitute the existing recombinant technology in therapeutics and drug discovery.
The RNAi technologies market is witnessing numerous applications in agriculture, drug discovery, therapeutics, and medical research – specifically metabolism and functional genomics. Within the RNAi technology market, the therapeutics application segment can be further categorized as: neurology, oncology, ophthalmology, cardiology, and metabolic disorders. Based on the tools and products used for realizing Ribonucleic Acid Interference applications, the market can be classified into: libraries, software and vectors. Based on its type, RNAi technology can also be categorized as small interfering RNAi and micro RNAi.
The prospects look promising for the RNAi technologies market, especially given the anticipated double digit growth. As the market for Ribonucleic Acid Interference technologies develops, it could outperform current post-genomic-era technologies such as Recombinant DNA
Several key market players—duly backed by venture capitalists and investors—have made massive investments in applying RNAi technologies in developing oligonucleotide drugs. This industry has been a field not just for research and development, but also for numerous mergers and takeovers. Specialty companies are rapidly emerging in the RNAi technologies market, and will likely shape the future of this sector in the coming years. Among pharma giants that are looking for ways to fill their weak pipelines, many consider RNAi-based drugs as a lucrative solution for the same. Given that the RNAi technologies market is still at a nascent stage, companies are keen on earning an early-movers’ advantage.
Some of the key players in the RNAi technologies market are: Ambion, Qiagen, and Invitrogen.
This market research report analyzes the following geographies:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements in the micro servers industry
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments